RESEARCH TRIANGLE PARK, N.C. – September 14, 2011 – Quintiles was named 4th in the prestigious InformationWeek 500 technology innovators rankings for its Quintiles INFOSARIO™ platform in a gala awards ceremony at the St. Regis Monarch Beach Resort (California). The company was also recognized as the industry leader in the biotech and pharmaceutical category.

“Simple, intuitive and rapid to implement, we have built Quintiles INFOSARIO as an end-to-end business platform that empowers our biopharma customers to manage data as we do – a strategic asset that enables fast, smart decision making, which accelerates drug development and significantly reduces operating costs,” said Richard Thomas, Quintiles chief information officer. “It is a fantastic team effort over the long haul between functions such as business operations, IT and marketing, and we are delighted to receive this honor.”

With nearly three decades of drug development and commercialization experience, Quintiles was recognized for creating a compelling proposition to support the biopharma industry, building a bridge to the future where data is foundational. This, combined with Quintiles’ capabilities, fully integrated systems and deep industry expertise, makes it truly transformational.

“Over the last few years, we have been busy, diligently assembling the portfolio of clinical applications and patented technologies that we use internally, integrating and then virtualizing them as they are housed in our private cloud,” said Naz Haji, senior vice president, technology client services. “From our cloud, they are available on just about any device with a net connection – laptops, smart phones, iPads and more. We support them all. It is also massively scalable thanks to our incredibly high level of virtualization and compression.”

Quintiles INFOSARIO was introduced in June 2011.

“For 23 years, the InformationWeek 500 has chronicled and honored the most innovative users of business technology,” said InformationWeek Editor-in-Chief Rob Preston. “In this day and age, however, being innovative isn’t enough. Companies and their IT organizations need to innovate faster than ever before to stay a step or two ahead of their customers, partners and competitors. This year’s ranking placed special emphasis on those high-octane business technology innovators.” InformationWeek identifies and honors the nation’s most innovative users of information technology with its annual 500 listing, and also tracks the technology, strategies, investments and administrative practices of America’s best-known companies. Top winners have included: The Vanguard Group, CME Group, Conway, National Semiconductor, Kimberly-Clark, Hilton Hotels and Unum. The InformationWeek 500 rankings are unique among corporate rankings as they spotlight the power of innovation in information technology, rather than simply identifying the biggest IT spenders.

Additional details on the InformationWeek 500 can be found online at

About InformationWeek Business Technology Network

The InformationWeek Business Technology Network provides IT executives with unique analysis and tools that parallel their work flow—from defining and framing objectives through to the evaluation and recommendation of solutions. Anchored by InformationWeek, the multimedia powerhouse that looks across the enterprise, the network scales across the most critical technology categories with online properties like (security), (networking and communications) and (cloud computing). The network also provides focused content for key IT targets, such as CIOs, developers, and SMBs via InformationWeek Global CIO, Dr. Dobb’s and InformationWeek SMB, as well as vital vertical industries with InformationWeek Financial Services, Government, and Healthcare resources. Content is at the nucleus of our information distribution.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit